There were neither differences in baseline clinical characteristics between patients with SMC1A-mutated vs. SMC1A-wild-type AML (Table S12) nor between patients with SMC3-mutated vs. SMC3-wild-type AML (Table S13). The gene discussed is SMC3; the disease is acute myeloid leukemia.